Fundamental Analysis
67 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +103.0% | +43.9% | 2 / 3 | +60.4% | -0.53 pp | +0.47 pp | +24.1% | 2.21 | 3.07 | 1.456 | +60,4% | 45,3 | +88,9% | 3.07 | 22.67 | −86,4% |
| Pts | 12 | 8 | 8 | 12 | 4 | 8 | 12 | -4 | 12 | |||||||
Valuation annotation:Price: 12.200 (close price on 2026-10-19)EPS (TTM): 3.969
Financial charts
1.Revenue & growth
VND bn1.456Q2/26
1.Revenue & growth
VND bn1.456Q2/26
2.Profit & growth
VND bn39,5Q2/26
3.Profit mix (Penman)
VND bn252Q2/26
4.Margins & cost structure
%6.6%Q2/26
5.Returns & cash cycle
% · days9.0%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn6.155Q2/26
8.Funding & debt health
VND bn · times6.155Q2/26
9.Revenue backlog
VND bn1.753Q2/26
10.Valuation
times · %3,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %691Q2/26
Adjusted EPS growth, latest quarter
103%
Average adjusted EPS growth, 3 quarters
43.9%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26